DarioHealth Corp. (DRIO) vs Rapid Micro Biosystems, Inc. (RPID)

A side-by-side comparison of DarioHealth Corp. and Rapid Micro Biosystems, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — DRIO vs RPID

growth of $100 · dividends reinvested · last 5y
DRIO -98.2% (-55.5%/yr)RPID -95.4% (-46.1%/yr)RPID compounded faster over this window
050100Start $10020222023202420252026$2$5
DRIO RPID

DRIO vs RPID: by the numbers

  • •DRIO is the larger company ($45M vs $44M market cap).
  • •DRIO is profitable (322.77% net margin) while RPID runs a net loss (-145.56%).
  • •RPID grew revenue faster over the past five years (10.24% vs 10.10% CAGR).

Metrics side by side

Valuation

MetricDRIORPID
P/E ratio8.88N/A
P/S ratio2.131.25
P/B ratio0.812.47

Profitability

MetricDRIORPID
Gross margin56.09%22.65%
Operating margin-163.94%-141.45%
Net margin322.77%-145.56%
ROE123.04%-288.49%
ROIC-78.42%-123.47%

Growth (annualized)

MetricDRIORPID
Revenue CAGR (5Y)10.10%10.24%
Total return CAGR (5Y)-52.92%-44.09%

Frequently asked

Which has grown faster, DRIO or RPID?
Over the past five years, RPID grew revenue faster — DRIO at a 10.10% CAGR versus RPID at 10.24%.
Is DRIO or RPID more profitable?
DRIO runs the higher net margin — DRIO at 322.77% versus RPID at -145.56%.
How have DRIO and RPID total returns compared?
Over the past 5 years, DRIO delivered -52.92% and RPID delivered -44.09% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.